Search results
Results from the WOW.Com Content Network
The Canadian formulation of Preparation H includes a yeast extract called Biodyne which was removed in 1995 from the formulation sold in the United States. This yeast extract was the primary ingredient of the original formulation by inventor George Sperti , [ 5 ] [ 6 ] and Pfizer believes that it removes wrinkles from skin and heals dry ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Lufenuron is a veterinary preparation (known as Program) that attacks the larval flea's ability to produce chitin, necessary for the adult's hard exoskeleton, but it does not kill fleas. Flea medicines need to be used with care because many of them also affect mammals. Pyrethrin based flea treatments meant for dogs can be hazardous to cats.
George Speri Sperti (January 17, 1900, Covington, Kentucky – April 29, 1991, Cincinnati, Ohio) was an Italian-American who invented Preparation H hemorrhoid medication. He also invented the Sperti Ultraviolet Lamp, Aspercreme for pain relief, and KVa Power Meter. [1] [2] Sperti graduated from the University of Cincinnati in 1923. Shortly ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
The Andrex Puppy, seen here in a British advertisement from 1994.. Andrex is a British brand of toilet roll.It is owned by the American company Kimberly-Clark. [2] The "Andrex Puppy", a Labrador Retriever puppy that appears on the company's television advertisements, is synonymous with the brand.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
In 2001, the company revealed an adhesive band-aid product in a joint venture with German personal care products maker Beiersdorf AG. [23] In 2003, 3M initiated contact with Yunnan Baiyao Group Co, Ltd. to discuss potential cooperation opportunities in the area of transdermal pharmaceutical products. [24]